4.3 Editorial Material

Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity

Related references

Note: Only part of the references are listed.
Review Oncology

Fertility Preservation: A Key Survivorship issue for Young women with Cancer

Ana Milena Angarita et al.

FRONTIERS IN ONCOLOGY (2016)

Review Pharmacology & Pharmacy

Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists

Zeev Blumenfeld et al.

EXPERT OPINION ON PHARMACOTHERAPY (2015)

Article Medicine, General & Internal

Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

Halle C. F. Moore et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Obstetrics & Gynecology

Protecting Ovaries During Chemotherapy Through Gonad Suppression A Systematic Review and Meta-analysis

Eman Elgindy et al.

OBSTETRICS AND GYNECOLOGY (2015)

Article Obstetrics & Gynecology

Gonadatrophin Suppression to Prevent Chemotherapy-Induced Ovarian Damage A Randomized Controlled Trial

Eman A. Elgindy et al.

OBSTETRICS AND GYNECOLOGY (2013)

Review Hematology

Management of fertility in patients treated for Hodgkin's lymphoma

Stephanie Harel et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)

Review Oncology

Fertility preservation after chemotherapy for Hodgkin lymphoma

Marleen A. E. van der Kaaij et al.

HEMATOLOGICAL ONCOLOGY (2010)